
Horizon Therapeutics Public Company Investor Relations Material
Latest events

Q3 2022
Horizon Therapeutics Public Company

Investor Presentation
8 Aug, 2023

Q2 2023
8 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Horizon Therapeutics Public Limited Company
Access all reports
Horizon Therapeutics Public Limited Company was a biopharmaceutical company focused on the development and commercialization of treatments for rare, autoimmune, and severe inflammatory diseases. The company marketed a portfolio of therapies in North America and internationally. Horizon Therapeutics Public Limited Company was headquartered in Dublin, Ireland, and its shares were listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
HZNP
Country
🇺🇸 United States